PT556152E - Derivados piridinio e sua utilizacao na determinacao de disturbios do tecido conjuntivo em humanos e animais - Google Patents

Derivados piridinio e sua utilizacao na determinacao de disturbios do tecido conjuntivo em humanos e animais

Info

Publication number
PT556152E
PT556152E PT93810049T PT93810049T PT556152E PT 556152 E PT556152 E PT 556152E PT 93810049 T PT93810049 T PT 93810049T PT 93810049 T PT93810049 T PT 93810049T PT 556152 E PT556152 E PT 556152E
Authority
PT
Portugal
Prior art keywords
humans
animals
determination
pyridine derivatives
conjunctive tissue
Prior art date
Application number
PT93810049T
Other languages
English (en)
Inventor
Rudolf Waelchli
Laszlo Revesz
Original Assignee
Novartis Ag
Novartis Erfind Verwalt Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag, Novartis Erfind Verwalt Gmbh filed Critical Novartis Ag
Publication of PT556152E publication Critical patent/PT556152E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/65One oxygen atom attached in position 3 or 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Soft Magnetic Materials (AREA)
  • Paper (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
PT93810049T 1992-01-31 1993-01-26 Derivados piridinio e sua utilizacao na determinacao de disturbios do tecido conjuntivo em humanos e animais PT556152E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929202139A GB9202139D0 (en) 1992-01-31 1992-01-31 Improvements in or relating to organic compounds

Publications (1)

Publication Number Publication Date
PT556152E true PT556152E (pt) 2002-05-31

Family

ID=10709643

Family Applications (1)

Application Number Title Priority Date Filing Date
PT93810049T PT556152E (pt) 1992-01-31 1993-01-26 Derivados piridinio e sua utilizacao na determinacao de disturbios do tecido conjuntivo em humanos e animais

Country Status (16)

Country Link
EP (1) EP0556152B1 (pt)
JP (1) JP3544549B2 (pt)
AT (1) ATE210645T1 (pt)
AU (1) AU663909B2 (pt)
CA (1) CA2088396A1 (pt)
CZ (1) CZ288038B6 (pt)
DE (1) DE69331293T2 (pt)
DK (1) DK0556152T3 (pt)
ES (1) ES2169723T3 (pt)
FI (1) FI104896B (pt)
GB (1) GB9202139D0 (pt)
HU (1) HU214677B (pt)
NO (1) NO180779C (pt)
PT (1) PT556152E (pt)
SG (1) SG43065A1 (pt)
SK (1) SK281137B6 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5620861A (en) * 1992-07-31 1997-04-15 Metra Biosystems, Inc. Method and kit for pyridinium crosslink assay
US5736344A (en) * 1992-12-17 1998-04-07 Metra Biosystems, Inc. Serum pyridinium crosslinks assay
US5756361A (en) * 1992-12-17 1998-05-26 Metra Biosystems, Inc. Screening method for periodontal disease
US5661039A (en) * 1995-03-01 1997-08-26 Metra Biosystems, Inc. Perspiration assay for bone resorption
US5723619A (en) * 1997-01-13 1998-03-03 Bayer Corporation Method for the synthesis of deoxypyridinoline
US5834610A (en) * 1997-05-06 1998-11-10 Johnson; Gary M. Conversion of pyridinoline to deoxypyridinoline
CN105801688A (zh) * 2016-04-14 2016-07-27 苏州博源医疗科技有限公司 脱氧吡啶酚免疫原、抗体和检测试剂及制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59148766A (ja) * 1983-02-10 1984-08-25 Otsuka Pharmaceut Co Ltd ピリジン誘導体
US4973666A (en) * 1987-11-06 1990-11-27 Washington Research Foundation Peptide fragments containing HP and LP cross-links
GB8929366D0 (en) * 1989-12-30 1990-02-28 Rowett Research Inst Method to detect connective tissue disorder in humans and animals

Also Published As

Publication number Publication date
NO930284D0 (no) 1993-01-28
SK4293A3 (en) 1993-11-10
AU3210593A (en) 1993-08-05
HUT70276A (en) 1995-09-28
FI104896B (fi) 2000-04-28
GB9202139D0 (en) 1992-03-18
HU214677B (hu) 1998-04-28
CA2088396A1 (en) 1993-08-01
CZ288038B6 (cs) 2001-04-11
DE69331293D1 (de) 2002-01-24
EP0556152B1 (en) 2001-12-12
ATE210645T1 (de) 2001-12-15
ES2169723T3 (es) 2002-07-16
FI930367A (fi) 1993-08-01
NO930284L (no) 1993-08-02
JPH0641078A (ja) 1994-02-15
HU9300108D0 (en) 1993-04-28
FI930367A0 (fi) 1993-01-28
JP3544549B2 (ja) 2004-07-21
AU663909B2 (en) 1995-10-26
EP0556152A1 (en) 1993-08-18
NO180779C (no) 1997-06-18
SK281137B6 (sk) 2000-12-11
SG43065A1 (en) 1997-10-17
DE69331293T2 (de) 2002-07-18
NO180779B (no) 1997-03-10
CZ10693A3 (en) 1993-12-15
DK0556152T3 (da) 2002-04-08

Similar Documents

Publication Publication Date Title
DE69018908D1 (de) N-aryl und N-Heteroarylamide und Harnstoffderivate als Inhibitoren von Acyl-Coenzym A: Cholesterol-Acyl-Transferase.
ES2078291T3 (es) Nuevos derivados de acido a-nor-esteroide-3-carboxilico.
ATE86247T1 (de) 3-indolpyruvsaeure-derivate und deren verwendung als arznemittel.
ES2125927T3 (es) Nuevo metodo de producir 9-((glicilo substituido)amino)-6-desmetil-6-desoxitetraciclinas substituidas en la posicion 7.
GR3030165T3 (en) N-heteroaryl-n'-phenylurea derivatives, their production and use.
PT556152E (pt) Derivados piridinio e sua utilizacao na determinacao de disturbios do tecido conjuntivo em humanos e animais
ES2131313T3 (es) Derivados de acido nipecotico como compuestos antitromboticos.
ES2099703T3 (es) Derivados de piridina.
NO880557L (no) Pyridin-2,4- og 2,5-dikarboksylsyrederivater, samt fremgangsmaate forfremstilling av forbindelsene.
ATE353937T1 (de) Verfahren zur synthese einer oxonolverbindung
DE69403537D1 (de) Verfahren zur Synthese von halbsynthetischen Glykosaminoglykanen mit Heparin- oder Heparanstruktur, die in 2-Position modifiziertes Alpha-L-Iduronsäure-2-O-Sulfat enthalten
ES2019981B3 (es) Amido acido benzofurancarbono basico sustituido, metodo de fabricacion y productos terapeuticos contenidos
FR2555578B1 (fr) Procede de preparation de derives d'azetidinone
MX9100345A (es) Procedimiento para la preparacion de derivados 6-(aminopropionil sustituidos)de forscolina
HUT59150A (en) Process for producing heterocyclic nmda antagonists
DE69012845D1 (de) Exo-3'-4'-O-benzyliden-3"-demethylchartreusin und seine Salze.
FI953290A (fi) Uusia syklopropyylijohdannaisia, menetelmä niiden valmistamiseksi ja niiden käyttö
ATE97447T1 (de) Antibiotikum 6270b, verfahren zu seiner herstellung und seine verwendung als anticoccidiosemittel und futterzusatz.
RO95169A2 (ro) Procedeu de atomizare a suspensiilor